Considering that the main pathological mechanism in MS are inflammation and demyelination and that RTN-4A and its receptor NgR1 may modulate both processes, it seems crucial and justifiable to know better the role of this protein in the disease progression. This evidence concerns the gene RTN4R and myeloid sarcoma.